The average wholesale prices of the originator insulin are around $329 per vial and $510 for five pens, according to Civica, which says it will start clinical trials of the biosimilars this year ...
If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...
Minnesota Attorney General Keith Ellison and pharmaceutical company Novo Nordisk reached a settlement to cap insulin costs at ...
Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a rise in generic options. Insulin prices averaged 19 cents per unit as ...
The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 ...
"High list prices also make insulin unaffordable for other patients ... will cost no more than $30 per vial or $55 for five pen cartridges, adding that compares to around $329 per vial and $ ...
As insulin prices in the United States continue to rise, making it increasingly difficult for diabetic patients to afford ...
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions of its drug — Semglee cost $269 and a generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback